The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease.

Simple item page
dc.contributor.authorO'Brien, Stephen
dc.contributor.authorKavanagh, Richard G.
dc.contributor.authorCarey, Brian W.
dc.contributor.authorMaher, Michael M.
dc.contributor.authorO'Connor, Owen J.
dc.contributor.authorAndrews, Emmet J.
dc.date.accessioned2018-11-27T14:34:00Z
dc.date.available2018-11-27T14:34:00Z
dc.date.issued2018-11-21
dc.date.updated2018-11-23T14:51:07Z
dc.description.abstractBackground: Inflammatory bowel disease (IBD) is a relatively common disorder with significant associated morbidity. Sarcopenia and myosteatosis are associated with adverse postoperative outcomes. This study investigated outcomes in IBD patients undergoing surgical resection relative to the presence of sarcopenia and myosteatosis. Methods: A retrospective analysis of a prospectively maintained surgical database was conducted. All patients undergoing elective or emergency resection for IBD between 2011 and 2016, with a contemporaneous perioperative computed tomography (CT) scan, were included. Patient demographics, clinical and biochemical measurements were collected. Skeletal muscle index and attenuation were measured on perioperative CT scans using Osirix version 5.6.1. Univariate and multivariate regression analysis was used to identify risk factors for adverse postoperative outcomes. Results: Seventy-seven patients (46 male, 31 female; mean age 42 years, range 20–80 years) were included. Thirty patients (30%) had sarcopenia and 26 (34%) had myosteatosis. Myosteatosis was significantly associated with increased hospital stay postoperatively (9 versus 13 days). Sarcopenia and myosteatosis were associated with hospital readmission within 30 days on univariate analysis. Multivariate regression analysis demonstrated an independent association between myosteatosis and hospital readmission. Sixteen patients (21%) had a clinically relevant postoperative complication, but an association with sarcopenia and myosteatosis was not observed. A neutrophil-lymphocyte ratio greater than 5 was predictive of clinically relevant postoperative complications on multivariate regression analysis. Conclusions: Myosteatosis was associated with increased hospital stay and increased 30-day hospital readmission rates on multivariate regression analysis. Sarcopenia and myosteatosis in IBD were not associated with clinically relevant postoperative complications.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationO'Brien, S., Kavanagh, R. G., Carey, B. W., Maher, M. M., O’Connor, O. J. and Andrews, E. J. (2018) 'The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease', European Radiology Experimental, 2(1), 37 (10 pp). doi: 10.1186/s41747-018-0072-3en
dc.identifier.doi10.1186/s41747-018-0072-3
dc.identifier.endpage37-10en
dc.identifier.issn2509-9280
dc.identifier.journaltitleEuropean Radiology Experimentalen
dc.identifier.startpage37-1en
dc.identifier.urihttps://hdl.handle.net/10468/7154
dc.identifier.volume2en
dc.language.isoenen
dc.publisherSpringer Openen
dc.rights© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectSarcopeniaen
dc.subjectCTen
dc.subjectMyosteatosisen
dc.subjectRadiometricsen
dc.subjectInflammatory bowel diseasesen
dc.subjectMuscle (skeletal)en
dc.subjectMorbidityen
dc.subjectLength of stayen
dc.subjectTomography (x-ray computed)en
dc.subject~Medicine - Journal Articles~en
dc.titleThe impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease.en
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
oj_IBD_Sarcopenia_Final_Draft_Blinded.docx
Size:
103.62 KB
Format:
Microsoft Word XML
Description:
Author's original
Thumbnail Image
Name:
8429_s41747-018-0072-3.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
School of Medicine